These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 28458436)

  • 1. Response to eperisone in patients of therapy-resistant dissociative convulsions: A report of two cases.
    Jha VN; Singh PK
    Indian J Pharmacol; 2017; 49(1):121-123. PubMed ID: 28458436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Open experience with a new myorelaxant agent for low back pain.
    Sartini S; Guerra L
    Adv Ther; 2008 Oct; 25(10):1010-8. PubMed ID: 18836866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and tolerability of eperisone and baclofen in spastic palsy: a double-blind randomized trial.
    Bresolin N; Zucca C; Pecori A
    Adv Ther; 2009 May; 26(5):563-73. PubMed ID: 19458926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical experience with eperisone in the treatment of acute low back pain.
    Beltrame A; Grangiè S; Guerra L
    Minerva Med; 2008 Aug; 99(4):347-52. PubMed ID: 18663343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of eperisone in patients with spastic palsy: a cross-over, placebo-controlled dose-ranging trial.
    Bresolin N; Zucca C; Pecori A
    Eur Rev Med Pharmacol Sci; 2009; 13(5):365-70. PubMed ID: 19961042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of tardive dystonia with an antispastic agent.
    Nisijima K; Shimizu M; Ishiguro T
    Acta Psychiatr Scand; 1998 Oct; 98(4):341-3. PubMed ID: 9821458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of eperisone hydrochloride in the treatment of acute musculoskeletal spasm associated with low back pain: a randomized, double-blind, placebo-controlled trial.
    Chandanwale AS; Chopra A; Goregaonkar A; Medhi B; Shah V; Gaikwad S; Langade DG; Maroli S; Mehta SC; Naikwadi A; Pawar DR
    J Postgrad Med; 2011; 57(4):278-85. PubMed ID: 22120855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of eperisone in patients with low back pain: a double blind randomized study.
    Cabitza P; Randelli P
    Eur Rev Med Pharmacol Sci; 2008; 12(4):229-35. PubMed ID: 18727454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eperisone compared to physiotherapy on muscular tone of stroke patients: a prospective randomized open study.
    Tariq M; Akhtar N; Ali M; Rao S; Badshah M; Irshad M
    J Pak Med Assoc; 2005 May; 55(5):202-4. PubMed ID: 15960286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical application of eperisone hydrochloride to neurogenic bladder].
    Murayama K; Katsumi T; Tajika E; Nakamura T
    Hinyokika Kiyo; 1984 Mar; 30(3):403-8. PubMed ID: 6464913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eperisone Hydrochloride, a Muscle Relaxant, Is a Potent P2X7 Receptor Antagonist.
    Okada M; Nose T
    Chem Pharm Bull (Tokyo); 2024; 72(3):345-348. PubMed ID: 38556262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-lasting muscle relaxant activity of eperisone hydrochloride after percutaneous administration in rats.
    Matsunaga M; Uemura Y; Yonemoto Y; Kanai K; Etoh H; Tanaka S; Atsuta Y; Nishizawa Y; Yamanishi Y
    Jpn J Pharmacol; 1997 Mar; 73(3):215-20. PubMed ID: 9127816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy and safety of eperisone in patients with cervical spondylosis: results of a randomized, double-blind, placebo-controlled trial.
    Bose K
    Methods Find Exp Clin Pharmacol; 1999 Apr; 21(3):209-13. PubMed ID: 10389124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Personal experiences with myotonolytics].
    Vurdelja N; Orovcanec K
    Med Pregl; 1969; 22(5-6):263-6. PubMed ID: 5396216
    [No Abstract]   [Full Text] [Related]  

  • 15. Eperisone versus tizanidine for treatment of chronic low back pain.
    Rossi M; Ianigro G; Liberatoscioli G; Di Castelnuovo A; Grimani V; Garofano A; Camposarcone N; Nardi LF
    Minerva Med; 2012 Jun; 103(3):143-9. PubMed ID: 22653094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transdermal eperisone elicits more potent and longer-lasting muscle relaxation than oral eperisone.
    Yang SI; Park HY; Lee SH; Lee SJ; Han OY; Lim SC; Jang CG; Lee WS; Shin YH; Kim JJ; Lee SY
    Pharmacology; 2004 Jul; 71(3):150-6. PubMed ID: 15161997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are some cases of sleep paralysis an expression of a dissociative condition? Dramatic resolution of sleep paralysis in an adolescent after administration of aripiprazole.
    Donfrancesco R; Melegari MG; Giua E; Bruni O
    Sleep Med; 2017 Apr; 32():267-268. PubMed ID: 28057494
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacokinetic interactions between eperisone hydrochloride and aceclofenac: a randomized, open-label, crossover study of healthy Korean men.
    Kim MJ; Lim HS; Noh YH; Kim YH; Choi HY; Park KM; Kim SE; Bae KS
    Clin Ther; 2013 Oct; 35(10):1528-35. PubMed ID: 24050970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of tinnitus severity by the centrally acting muscle relaxant cyclobenzaprine: an open-label pilot study.
    Coelho C; Figueiredo R; Frank E; Burger J; Schecklmann M; Landgrebe M; Langguth B; Elgoyhen AB
    Audiol Neurootol; 2012; 17(3):179-88. PubMed ID: 22302057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Status of the therapy of multiple sclerosis].
    Bas H
    Ther Ggw; 1967 Oct; 106(10):1319-25. PubMed ID: 4314784
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.